These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19737558)

  • 1. Adenosine mediates transforming growth factor-beta 1 release in kidney glomeruli of diabetic rats.
    Roa H; Gajardo C; Troncoso E; Fuentealba V; Escudero C; Yáñez A; Sobrevia L; Pastor-Anglada M; Quezada C; San Martin R
    FEBS Lett; 2009 Oct; 583(19):3192-8. PubMed ID: 19737558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A(2B) receptor mediates an increase on VEGF-A production in rat kidney glomeruli.
    Valladares D; Quezada C; Montecinos P; Concha II; Yañez AJ; Sobrevia L; San Martín R
    Biochem Biophys Res Commun; 2008 Feb; 366(1):180-5. PubMed ID: 18060864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraglomerular Monocyte/Macrophage Infiltration and Macrophage-Myofibroblast Transition during Diabetic Nephropathy Is Regulated by the A
    Torres Á; Muñoz K; Nahuelpán Y; R Saez AP; Mendoza P; Jara C; Cappelli C; Suarez R; Oyarzún C; Quezada C; San Martín R
    Cells; 2020 Apr; 9(4):. PubMed ID: 32340145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A(2B) receptor-mediated VEGF induction promotes diabetic glomerulopathy.
    Cárdenas A; Toledo C; Oyarzún C; Sepúlveda A; Quezada C; Guillén-Gómez E; Díaz-Encarnación MM; Pastor-Anglada M; San Martín R
    Lab Invest; 2013 Jan; 93(1):135-44. PubMed ID: 23069939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TGF-beta/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model.
    Ricci C; Iacobini C; Oddi G; Amadio L; Menini S; Rastaldi MP; Frasheri A; Pricci F; Pugliese F; Pugliese G
    Nephrol Dial Transplant; 2006 Jun; 21(6):1514-24. PubMed ID: 16449286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting adenosine signaling to treatment of diabetic nephropathy.
    Quezada C; Alarcón S; Jaramillo C; Muñoz D; Oyarzún C; San Martín R
    Curr Drug Targets; 2013 Apr; 14(4):490-6. PubMed ID: 23316933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia.
    Escudero C; Casanello P; Sobrevia L
    Placenta; 2008 Sep; 29(9):816-25. PubMed ID: 18703227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulphate proteoglycans and diabetic nephropathy.
    van der Woude FJ; van Det NF
    Exp Nephrol; 1997; 5(3):180-8. PubMed ID: 9208276
    [No Abstract]   [Full Text] [Related]  

  • 9. Halofuginone prevents extracellular matrix deposition in diabetic nephropathy.
    Sato S; Kawamura H; Takemoto M; Maezawa Y; Fujimoto M; Shimoyama T; Koshizaka M; Tsurutani Y; Watanabe A; Ueda S; Halevi K; Saito Y; Yokote K
    Biochem Biophys Res Commun; 2009 Feb; 379(2):411-6. PubMed ID: 19114027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient Insulin-mediated Upregulation of the Equilibrative Nucleoside Transporter 2 Contributes to Chronically Increased Adenosine in Diabetic Glomerulopathy.
    Alarcón S; Garrido W; Vega G; Cappelli C; Suárez R; Oyarzún C; Quezada C; San Martín R
    Sci Rep; 2017 Aug; 7(1):9439. PubMed ID: 28842605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral nephrectomy leads to up-regulation of syndecan-2- and TGF-beta-mediated glomerulosclerosis in syndecan-4 deficient male mice.
    Cevikbas F; Schaefer L; Uhlig P; Robenek H; Theilmeier G; Echtermeyer F; Bruckner P
    Matrix Biol; 2008 Jan; 27(1):42-52. PubMed ID: 17681770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A2BAR Antagonism Decreases the Glomerular Expression and Secretion of Chemoattractants for Monocytes and the Pro-Fibrotic M2 Macrophages Polarization during Diabetic Nephropathy.
    Torres-Arévalo Á; Nahuelpán Y; Muñoz K; Jara C; Cappelli C; Taracha-Wiśniewska A; Quezada-Monrás C; Martín RS
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transforming growth factor-beta (TGF-beta), keystone in diabetic nephropathy].
    López-Casillas F
    Rev Invest Clin; 2000; 52(5):487-90. PubMed ID: 11195175
    [No Abstract]   [Full Text] [Related]  

  • 14. Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis.
    Sakai T; Nambu T; Katoh M; Uehara S; Fukuroda T; Nishikibe M
    Biochem Biophys Res Commun; 2009 Jun; 384(2):173-9. PubMed ID: 19401193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transforming growth factor-beta and determination of apoptotic index in histopathological sections for assessment of the effects of Apigenin (4', 5', 7'- Trihydroxyflavone) on Cyclosporine A induced renal damage.
    Chong FW; Chakravarthi S; Nagaraja HS; Thanikachalam PM; Lee N
    Malays J Pathol; 2009 Jun; 31(1):35-43. PubMed ID: 19694312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Adenosine Uptake and Its Contribution to Signaling that Mediates Profibrotic Activation in Renal Tubular Epithelial Cells: Implication in Diabetic Nephropathy.
    Kretschmar C; Oyarzún C; Villablanca C; Jaramillo C; Alarcón S; Perez G; Díaz-Encarnación MM; Pastor-Anglada M; Garrido W; Quezada C; San Martín R
    PLoS One; 2016; 11(1):e0147430. PubMed ID: 26808537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy.
    Ziyadeh FN; Sharma K
    Kidney Int Suppl; 1995 Sep; 51():S34-6. PubMed ID: 7474686
    [No Abstract]   [Full Text] [Related]  

  • 18. Defective insulin-stimulated equilibrative nucleoside transporter-2 activity and altered subcellular transporter distribution drive the loss of adenosine homeostasis in diabetic kidney disease progression.
    Suarez R; Villarreal C; Nahuelpán Y; Jara C; Oyarzún C; Alarcón S; Díaz-Encarnación MM; Guillén-Gómez E; Quezada C; San Martín R
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166890. PubMed ID: 37734469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical forces in diabetic kidney disease: a trigger for impaired glucose metabolism.
    Gnudi L; Thomas SM; Viberti G
    J Am Soc Nephrol; 2007 Aug; 18(8):2226-32. PubMed ID: 17634438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the regulation of inflammation by adenosine.
    Linden J
    J Clin Invest; 2006 Jul; 116(7):1835-7. PubMed ID: 16823484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.